Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anne-Marie Lund Winther | M | - |
Pcovery ApS
 Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | 14 years |
| Mikael Søndergaard Thomsen | M | 56 |
Conrig Pharma ApS
 Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark. | 14 years |
| Casper Hansen | M | - |
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | 11 years |
| Niels Skjærbæk | M | - |
Conrig Pharma ApS
Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark. | - |
| William Dalby-Brown | M | - |
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | - |
| Emmanuelle Coutanceau | M | 44 |
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | - |
| Klaus Schollmeier | M | 67 |
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | 9 years |
| Ilka Wicke | M | - |
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | - |
| Katrine Sperling | F | - | 22 years | |
| Tania Sabroe | F | 47 | 17 years | |
| Michael Broberg Palmgren | M | - |
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | 15 years |
| Poul Nissen | M | - |
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | 15 years |
| Martin Lange | M | 54 | 22 years | |
| Frank Odds | M | - |
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Göran Albert Ando | M | 75 | 13 years | |
| Sten Scheibye | M | 72 | 10 years | |
| Robert Frederick Caspari | M | 78 | 4 years | |
| Marianne Kock | F | 69 | 17 years | |
| Adam Sinding Steensberg | M | 50 | 4 years | |
| Karen Lauberg Lauritsen | F | 56 | 12 years | |
| Nicolai Buhl Andersen | M | - | 4 years | |
| Jesper Høiland | M | 63 | 8 years | |
| Christopher Yallop | M | - | 6 years | |
| Per Gunnar Falk | M | - | - | |
| Henrik Gürtler | M | 70 | - | |
| Finn M. Ulrich | M | - | 8 years | |
| Carsten Boess | M | 57 | 13 years | |
| Terje Kalland | M | 73 | 6 years | |
| Thorkil Kastberg Christensen | M | 75 | 25 years | |
| Pamela Kirby | M | 70 | 3 years | |
| Peter Helt Jacobsen Haahr | M | 56 | - | |
| Jan Ulf Sigvar J. Johansson | M | 79 | 7 years | |
| Peter Gerhardsson | M | - | 3 years | |
| Eva Ehrnrooth | M | 57 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Denmark | 34 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Bondo Hansen
- Personal Network